Paper5960883
Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.
Nelson RA and 3 others. Immunochemistry, 1966. Cited by 883 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum. Papers, record 5960883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5960883
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Complement System Proteins | Major topic |
| Animals | |
| Chromatography | |
| Dialysis | |
| Guinea Pigs | |
| Hemolysis | |
| Hydrogen-Ion Concentration |
Source PubMed
Cited by248
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 883 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33,165,871 | Liposome Formulations as Adjuvants for Vaccines. | Curr Top Microbiol Immunol | 2021 | https://conductscience.org/library/papers/33165871 | PubMed |
| 24,672,678 | The complement system: history, pathways, cascade and inhibitors. | Eur J Microbiol Immunol (Bp) | 2012 | https://conductscience.org/library/papers/24672678 | PubMed |
| 24,535,721 | Cycloartane-type triterpene glycosides from Beesia calthaefolia and their anticomplement activity. | J Nat Med | 2014 | https://conductscience.org/library/papers/24535721 | PubMed |
| 20,929,344 | Short communication: quantitative proteomic plasma profiling reveals activation of host defense to oxidative stress in chronic SIV and methamphetamine comorbidity. | AIDS Res Hum Retroviruses | 2011 | https://conductscience.org/library/papers/20929344 | PubMed |
| 20,844,193 | C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes. | J Immunol | 2010 | https://conductscience.org/library/papers/20844193 | PubMed |
| 18,400,428 | Anticomplementary principles of a Chinese multiherb remedy for the treatment and prevention of SARS. | J Ethnopharmacol | 2008 | https://conductscience.org/library/papers/18400428 | PubMed |
| 15,776,568 | The antigenic and molecular alterations of C3 in the fluid phase during an immune reaction in normal human serum. Demonstration of a new conversion product, C3x. | J Exp Med | 1971 | https://conductscience.org/library/papers/15776568 | PubMed |
| 11,344,568 | Hereditary deficiency of the sixth component of complement in man. I. Immunochemical, biologic, and family studies. | J Clin Invest | 1974 | https://conductscience.org/library/papers/11344568 | PubMed |
| 11,344,546 | Serum heat-labile opsonins in systemic lupus erythematosus. | J Clin Invest | 1974 | https://conductscience.org/library/papers/11344546 | PubMed |
| 11,107,496 | Complement deficiency. | Clin Rev Allergy Immunol | 2000 | https://conductscience.org/library/papers/11107496 | PubMed |
| 9,366,565 | Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclin-dependent kinase antagonist. | J Clin Invest | 1997 | https://conductscience.org/library/papers/9366565 | PubMed |
| 7,813,102 | Low activity of the classical complement pathway predicts short survival of patients with chronic lymphocytic leukaemia. | Clin Exp Immunol | 1995 | https://conductscience.org/library/papers/7813102 | PubMed |
| 7,730,143 | Mannose-binding protein recognizes glioma cells: in vitro analysis of complement activation on glioma cells via the lectin pathway. | Jpn J Cancer Res | 1995 | https://conductscience.org/library/papers/7730143 | PubMed |
| 7,528,766 | Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. | J Exp Med | 1995 | https://conductscience.org/library/papers/7528766 | PubMed |
| 7,429,548 | Complement receptors on Raji cells. The presence of a new type of C3 receptor. | Immunology | 1980 | https://conductscience.org/library/papers/7429548 | PubMed |
| 7,409,863 | Genetic polymorphism of a serum euglobulin of chickens which binds to antigen-antibody complexes. | Immunogenetics | 1980 | https://conductscience.org/library/papers/7409863 | PubMed |
| 7,400,327 | Erythropoietic protoporphyria. Photoactivation of the complement system. | J Clin Invest | 1980 | https://conductscience.org/library/papers/7400327 | PubMed |
| 7,364,952 | A method for the estimation of the activity of the inhibitor of the first component of complement. | J Clin Pathol | 1980 | https://conductscience.org/library/papers/7364952 | PubMed |
| 7,358,423 | Analysis of the anticomplementary activity in sera of three African patients with parasitic and bacteriological infections. | Infect Immun | 1980 | https://conductscience.org/library/papers/7358423 | PubMed |
| 7,316,962 | The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum. | Biochem J | 1981 | https://conductscience.org/library/papers/7316962 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5960883
GET https://conductscience.org/api/papers/v1/5960883/cited_by?page=2